ArticleAIDS and behavior2026
Experiences of Testing Negative or Positive for HIV in Malawi, South Africa, and Zambia: A Cross-Sectional Study.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05902572 (Outcomes of Differentiated Models of Service Delivery for HIV Treatment at Sentinel Sites in Zambia), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Outcomes of Differentiated Models of Service Delivery for HIV Treatment at Sentinel Sites in Zambia (Sentinel-Zambia)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HIV testing services (HTS) increase HIV status awareness and serve as the gateway to prevention and treatment. Understanding clients' perspectives when accessing facility-based HTS is important to ensure comprehensive service provision, improve linkage to care, and ultimately contribute to better health outcomes. We surveyed a convenience sample of adults testing negative and positive at 42 health facilities in Malawi, South Africa, and Zambia from 9/2022-4/2023, using a structured questionnaire for HTS history, testing reasons, services received, and access to pre-exposure prophylaxis (PrEP) or treatment and qualitative questions for testing experiences. We enrolled 1,142 HTS clients (324 Malawi, 389 South Africa, 429 Zambia). Negative testers (approximately 2/3 of the sample) were more likely than positive testers to have tested previously (82% v 64% Malawi, 88% v 66% South Africa, 86% v 71% Zambia). Among participants who tested positive, ill health was most frequently reported as the reason for testing; negative testers most often reported testing voluntarily (for their information). Most positive testers reported initiating ART, but < 1/3 in Malawi and South Africa and 39% in Zambia said they received adherence counselling. The proportion of negative testers offered PrEP ranged from 27% of females in Malawi to 53% of females in Zambia. Participants in all three countries reported high satisfaction with HTS, but ART adherence counselling was not universally provided and prevention services were not offered to most negative testers. The large proportion of positive testers who had never been tested before and self-reported testing because of ill health remains a concern.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.